-
Electronic (PDF)
-
Site License
-
Enterprisewide
Aastrom Biosciences, Inc. Product Pipeline Analysis
Global Markets Direct, January 2009, Pages: 56
Aastrom Biosciences, Inc. Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.
1 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Company Snapshot 8
2.1 Key Information 8
2.2 Company Overview 8
3 Aastrom Biosciences, Inc. Pipeline Products 9
3.1 Aastrom Biosciences, Inc. Product Pipeline Analysis 9
3.1.1 Aastrom Biosciences, Inc. Pipeline Products By Equipment Type 9
3.1.2 Aastrom Biosciences, Inc. Pipeline Products By Development Stage 9
3.1.3 Aastrom Biosciences, Inc. Pipeline Products By Therapy Area 9
3.1.4 Aastrom Biosciences, Inc. Pipeline Products By Clinical Trials 10
3.1.5 Aastrom Biosciences, Inc. Pipeline Products By News Summary 11
3.2 Tissue Repair Cell Technology 11
3.2.1 Product Status 11
3.2.2 Product Description 11
3.2.3 Product Milestone 11
3.2.4 Tissue Repair Cell TechnologyClinical Trials 1 12
3.2.5 Tissue Repair Cell TechnologyClinical Trials 2 12
3.2.6 Tissue Repair Cell TechnologyClinical Trials 3 13
3.2.7 Tissue Repair Cell TechnologyClinical Trials 4 13
3.2.8 Tissue Repair Cell TechnologyClinical Trials 5 13
3.2.9 Tissue Repair Cell TechnologyClinical Trials 6 15
3.2.10 Tissue Repair Cell TechnologyClinical Trials 7 15
3.2.11 Tissue Repair Cell TechnologyClinical Trials 8 15
3.2.12 Product Patent Details 17
3.3 Neural Repair Cells (NRCs) 24
3.3.1 Product Status 24
3.3.2 Product Description 24
3.4 Cardiac Repair Cells 25
3.4.1 Product Status 25
3.4.2 Product Description 25
3.4.3 Product Milestone 25
3.4.4 Clinical Trials 26
3.4.5 Product Patent Details 29
3.5 Vascular Repair Cells 35
3.5.1 Product Status 35
3.5.2 Product Description 35
3.5.3 Product Milestone 35
3.5.4 Vascular Repair CellsClinical Trials 1 36
3.5.5 Vascular Repair CellsClinical Trials 2 36
3.5.6 Product Patent Details 37
3.6 Bone Repair Cells 43
3.6.1 Product Status 43
3.6.2 Product Description 43
3.6.3 Bone Repair CellsClinical Trials 1 43
3.6.4 Bone Repair CellsClinical Trials 2 44
3.6.5 Bone Repair CellsClinical Trials 3 44
3.6.6 Bone Repair CellsClinical Trials 4 44
3.6.7 Bone Repair CellsClinical Trials 5 45
3.6.8 Bone Repair CellsClinical Trials 6 45
3.6.9 Bone Repair CellsClinical Trials 7 45
3.6.10 Bone Repair CellsClinical Trials 8 46
3.6.11 Product Patent Details 46
4 Recent Developments 53
4.1 Product News 53
4.1.1 Apr 30, 2007: Aastrom Biosciences Initiates Adult Stem Cell Clinical Trial For Peripheral Arterial Disease 53
4.1.2 Feb 01, 2006: Aastrom Biosciences Reports Positive Human Jaw Bone Results 53
4.2 Clinical Trials 53
4.2.1 Apr 30, 2007: Aastrom Biosciences Initiates Adult Stem Cell Clinical Trial For Peripheral Arterial Disease 53
4.2.2 Feb 01, 2006: Aastrom Biosciences Reports Positive Human Jaw Bone Results 53
5 Appendix 54
5.1 Methodology 54
5.1.1 Coverage 54
5.1.2 Secondary Research 55
5.1.3 Primary Research 55
5.1.4 Expert Panel Validation 56
5.2 Contact Us 56
5.3 About us56
5.4 Disclaimer 56
Executive Summary
1.2 List of Figures
Figure 1: Aastrom Biosciences, Inc. Pipeline Products By Clinical Trials 10
Figure 2: Global Markets Direct Methodology 54
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
